ResearchSpace
metadata only
Bio-inspired Solid Lipid Nanoparticles for therapeutic siRNA delivery targeting the LRRK2 G2019S mutation in a Parkinson’s disease cell model.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- An N-acylphosphatidylethanolamine-LRRK2 axis controls lysosomal homeostasis in Parkinson s disease#329313
- mRNA lipid nanoparticle vaccines: current status, challenges and future prospects.#1147112
- Allogenic transplantation therapy of iPS cell-derived dopamine progenitors for Parkinson's disease -Current status of the Kyoto Trial and future perspectives-#785360
- Allogenic transplantation therapy of iPS cell-derived dopamine progenitors for Parkinson's disease -Current status of the Kyoto Trial and future perspectives-#785329
- LIPId Profile Changes in Inflammatory Conditions Induced by SARS-CORoronavirus-2#846805
Record · ID 215983
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive